Aron Green, MD
Foot and Ankle Surgery · Ocean, NJNPI 1891726238
Payments from drug & device makers
What this record shows
The money is spread across several categories — consulting fees (40.9%), royalties or licence payments and food and beverage — rather than concentrated in one kind of arrangement. 37 manufacturers reported payments, led by Restor3d, Inc. at 31.2% of the total. Reporting peaked in 2019 at $23,191 and has fallen 81.0% since, to $4,410 in 2025. Among foot and ankle surgery clinicians in NJ with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 150 payments — averaging $344.86 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Restor3d, Inc.$16K
- Integra Lifesciences Corporation$7K
- Zimmer Biomet$6K
- Ascension Orthopedics, Inc.$5K
- In2bones USA, LLC$5K
- Linvatec Corporation$3K
- plus $9K from 31 others
Across 1 payment — averaging $7351.50 each. Payments tied to a research study. These frequently flow through the physician to a hospital or research institution rather than to the physician personally.
- Stryker$7K
What the payments were for
- Royalty or licence$18,20335%
- Consulting fees$21,16141%
- Speaking & faculty fees$2,0004%
- Travel & lodging$2,7135%
- Food & beverage$7,53115%
- Education$1220%
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Restor3d, Inc. | 12 | $16,156 |
| Integra Lifesciences Corporation | 3 | $6,800 |
| Zimmer Biomet | 14 | $6,307 |
| Ascension Orthopedics, Inc. | 2 | $5,400 |
| In2bones USA, LLC | 12 | $4,720 |
| Linvatec Corporation | 15 | $2,896 |
| DNE LLC | 2 | $2,280 |
| Stryker(2 entities) | 26 | $1,805 |
| Trimed, Inc. | 2 | $1,437 |
| Acumed LLC | 9 | $1,260 |
| Extremity Medical | 6 | $451 |
| Tenex Health Inc. | 3 | $266 |
| Osteomed LLC | 3 | $236 |
| Novastep Inc. | 3 | $203 |
| Voom Medical Devices, Inc. | 2 | $166 |
| Ossio Inc | 3 | $155 |
| Arthrex | 3 | $145 |
| Paragon 28, Inc. | 2 | $141 |
| Johnson & Johnson | 5 | $119 |
| Smith+Nephew | 2 | $118 |
| Organogenesis Inc. | 1 | $106 |
| Globus Medical(2 entities) | 2 | $85 |
| Alafair Biosciences, Inc. | 1 | $73 |
| Kerecis Limited | 3 | $69 |
| Maruho Medical, Inc. | 1 | $53 |
| International Life Sciences | 1 | $50 |
| Trilliant Surgical LLC. | 1 | $35 |
| Amgen | 2 | $34 |
| Nalu Medical, Inc. | 1 | $26 |
| Convatec Inc. | 1 | $23 |
| Heron Therapeutics, Inc. | 1 | $21 |
| Medshape, Inc. | 1 | $20 |
| Abbott | 1 | $19 |
| Vertex | 1 | $15 |
| ERMI LLC | 1 | $15 |
| AstraZeneca | 1 | $13 |
| Arbor Pharmaceuticals, Inc. | 1 | $13 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- SALTO TALARIS TOTAL ANKLE PROSTHESIS$12,200
- PANTA NAIL$12,200
- TOTAL FOOT SYSTEM$12,200
- CADENCE ANKLE REPLACEMENT SYSTEM$12,200
- Nextremity Nextra Hammertoe$4,500
- CoLink$2,502
- SEAL$2,280
- OS2 VP$2,100
- COLINK PLATING SYSTEM$1,262
- Nextremity MSP$1,255
- Ankle Plating System$907
- IN2BONES USA$885
- Acutrak Headless Compression Screw System$794
- VARIAX$422
- BioBrace 23mm$384
- COLINK CFX$241
- IO FiX$179
- Viaflow$167
- Avitus Bone Harvester$128
- PECAPLASTY$121
How this compares
$51,729 in reported general payments places this provider in the 95th percentile of 542 foot and ankle surgery providers in New Jersey.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Diclofenac Sodium | 124 | $2,899 |
| Celecoxib | 14 | $455 |
| Meloxicam | 86 | $346 |
| Gabapentin | 31 | $319 |
| Lidocaine | 11 | $269 |
| Cephalexin | 14 | $123 |
| Ibuprofen | 14 | $107 |
| Tramadol Hcl | 19 | $86 |
| Oxycodone Hcl | 12 | $46 |
Paid to pharmacies, not to this prescriber.
Other foot and ankle surgery in Ocean
- John CozzarelliBelleville$932K
- Matthew RegulskiToms River$843K
- Michael SubikLyndhurst$529K
- Krupa PatelMorris Plains$281K
- Johanna GodoyWayne$254K
- Andrew BriefRidgewood$253K
- Mark SolomonCedar Knolls$232K
- Evan AdlerOld Bridge$195K
- Shane HollawellManasquan$169K
- Jacob ReinkrautRidgewood$80K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.